SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-069167
Filing Date
2024-03-15
Accepted
2024-03-15 16:18:49
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d800776dsc13g.htm SC 13G 74797
2 EX-99.1 d800776dex991.htm EX-99.1 4616
  Complete submission text file 0001193125-24-069167.txt   81216
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45385 | Film No.: 24755039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 705 HIGH STREET PALO ALTO CA 94301
Business Address 705 HIGH STREET PALO ALTO CA 94301 650-924-9424
TCG Crossover GP II, LLC (Filed by) CIK: 0001969280 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G